Search Details

Word: markets (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...question, though, is whether it's good to see more houses come onto the market. Rampant building was one of the things that helped foster the real estate bubble, after all. Are the same companies that didn't know when to stop prematurely hopping back in? The number of existing homes for sale has fallen over the past year, but we still have a 9.4-month supply on the market - nearly double the rate that's desirable. With desperate homeowners trying to sell, and foreclosures still piling up, are more houses what we need? (See pictures of high-end homes...

Author: /time Magazine | Title: Homebuilders Are Back At It — Should We Be Worried? | 8/11/2009 | See Source »

...builders have been selling more houses than they've been putting up. In the first three months of 2009, there were 52,000 single-family homes started. Over the same period of time, 87,000 were sold. At the current rate of sale, all the new homes on the market would be gone in 8.8 months. That's still above a more normal four- to six-month supply - but taking into account how long it takes to ramp up new construction, it's not necessarily an illogical time to start building. Consider how quickly that excess inventory has been burned...

Author: /time Magazine | Title: Homebuilders Are Back At It — Should We Be Worried? | 8/11/2009 | See Source »

...more effective in promoting bone density. In addition, the studies show that denosumab did not cause the serious side effects - including cancer and the disintegration of bone in the jaw - that are associated with bisphosphonate drugs like Boniva, Fosamax and Reclast, the most commonly prescribed osteoporosis drugs on the market. (See TIME's special report "America...

Author: /time Magazine | Title: Experimental Drug Helps Treat Osteoporosis | 8/11/2009 | See Source »

...clear how denosumab, should it win approval, would fit into the anti-osteoporosis market for treating postmenopausal women. Among these patients, the study suggests, the experimental compound would be slightly more effective at reducing fractures than the bisphosphonate drugs Fosamax (alendronate) and Boniva (ibandronate), but no better than Reclast (zoledronic acid), the once-a-year solution that doctors administer intravenously...

Author: /time Magazine | Title: Experimental Drug Helps Treat Osteoporosis | 8/11/2009 | See Source »

CAMBRIDGE, Mass. — As one of many Harvard students who remained in Cambridge this summer (woot woot, job market!), I soon learned that there are three types of Harvard affiliates on campus during the warmer months: those who eat in Annenberg, those who take their meals in Dudley, and those who make do with neither (generally subsisting on stale bread and a single jar of peanut butter over the course of three months...

Author: By Molly M. Strauss | Title: SurPRISE | 8/11/2009 | See Source »

Previous | 248 | 249 | 250 | 251 | 252 | 253 | 254 | 255 | 256 | 257 | 258 | 259 | 260 | 261 | 262 | 263 | 264 | 265 | 266 | 267 | 268 | Next